WEE1 and gastric cancer: Taken together, we demonstrate that high expression of WEE1 in advanced stages and/or accompanied with lymph node metastasis indicate poorer survival for gastric cancer patients and that targeting WEE1 would be a therapeutic benefit for gastric cancer patients.